Donald Trump has appointed Robert F. Kennedy Jr. as the new head of the Department of Health and Human Services.
This decision has caused concern in the market, as Kennedy is known for his skepticism of vaccines and criticism of the pharmaceutical industry.
Trump stated that HHS will be responsible for protecting Americans from harmful chemicals, pollutants, pesticides, and pharmaceutical products.
As a result of the announcement, vaccine stocks experienced a decline.